A 72-year-old woman has non-valvular atrial fibrillation with a CHA₂DS₂-VASc score of 4 (age ≥75 gives 2 points, plus hypertension and diabetes). She has no major bleeding history and normal renal function. According to Australian recommendations on stroke prevention in atrial fibrillation, what is the most appropriate management regarding oral anticoagulation?